- Home
- TALKW vs SNN Comparison
TALKW vs SNN Comparison
Compare TALKW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TALKW | SNN |
|---|---|---|
| Founded | 2012 | 1856 |
| Country | United States | United Kingdom |
| Employees | 521 | N/A |
| Industry | Medical/Nursing Services | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 13.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | TALKW | SNN |
|---|---|---|
| Price | $0.03 | $33.30 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | 64.2K | ★ 903.9K |
| Earning Date | 02-20-2025 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | $181,291,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $59.27 |
| Revenue Growth | ★ 31.50 | 5.35 |
| 52 Week Low | $0.20 | $23.91 |
| 52 Week High | $0.24 | $38.79 |
Technical Indicators
Market Signals| Indicator | TALKW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 51.59 |
| Support Level | $0.02 | $32.09 |
| Resistance Level | $0.03 | $33.28 |
| Average True Range (ATR) | 0.01 | 0.62 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 53.10 | 57.76 |
Price Performance
Historical ComparisonAbout TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.